Medy-Tox Inc (086900) - Total Liabilities

Latest as of September 2025: ₩119.26 Billion KRW ≈ $80.82 Million USD

Based on the latest financial reports, Medy-Tox Inc (086900) has total liabilities worth ₩119.26 Billion KRW (≈ $80.82 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Medy-Tox Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Medy-Tox Inc's total liabilities have evolved over time, based on quarterly financial data. See 086900 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Medy-Tox Inc Competitors by Total Liabilities

The table below lists competitors of Medy-Tox Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Cre8 Direct Ningbo Co Ltd SHE:300703	China	CN¥1.03 Billion
Tupy S.A SA:TUPY3	Brazil	R$6.99 Billion
Cigniti Technologies Limited NSE:CIGNITITEC	India	Rs3.50 Billion
Guangxi Bossco Environmental Protection Technology Co Ltd SHE:300422	China	CN¥7.95 Billion
Robo.ai Inc. NASDAQ:AIIO	USA	$104.16 Million
Larimar Therapeutics Inc NASDAQ:LRMR	USA	$50.48 Million
Shanthi Gears Limited NSE:SHANTIGEAR	India	Rs1.16 Billion
Jacquet Metal Service SA PA:JCQ	France	€786.00 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Medy-Tox Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 086900 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medy-Tox Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medy-Tox Inc (2013–2024)

The table below shows the annual total liabilities of Medy-Tox Inc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩144.38 Billion ≈ $97.84 Million	+5.28%
2023-12-31	₩137.14 Billion ≈ $92.94 Million	-18.49%
2022-12-31	₩168.24 Billion ≈ $114.02 Million	-5.60%
2021-12-31	₩178.22 Billion ≈ $120.78 Million	-21.27%
2020-12-31	₩226.37 Billion ≈ $153.41 Million	+39.40%
2019-12-31	₩162.38 Billion ≈ $110.04 Million	+14.01%
2018-12-31	₩142.43 Billion ≈ $96.52 Million	-24.76%
2017-12-31	₩189.29 Billion ≈ $128.28 Million	+7.34%
2016-12-31	₩176.35 Billion ≈ $119.51 Million	+95.80%
2015-12-31	₩90.07 Billion ≈ $61.04 Million	+3.62%
2014-12-31	₩86.92 Billion ≈ $58.91 Million	+364.10%
2013-12-31	₩18.73 Billion ≈ $12.69 Million	--

About Medy-Tox Inc

KQ:086900 Korea Biotechnology

Market Cap

$374.05 Million

₩551.96 Billion KRW

Market Cap Rank

#13867 Global

#427 in Korea

Share Price

₩83900.00

Change (1 day)

-4.00%

52-Week Range

₩77700.00 - ₩177900.00

All Time High

₩671543.08